← Scroll for more →
Cardiff Oncology, Inc. (CRDF)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.21
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.39
P/B Ratio
3.12
Institutional Ownership
27.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Laurion Capital Management LP | 3.10M | $4.0M | 4.52% | +451.6K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.90M | $3.0M | 4.23% | +39.6K | 2026-06-30 |
| Pfizer Inc | 2.41M | $3.0M | 3.52% | -- | 2026-06-30 |
| Franklin Resources Inc | 1.21M | $1.0M | 1.76% | -- | 2026-06-30 |
| BlackRock, Inc. | 972.9K | $1.0M | 1.42% | -3.01M | 2026-06-30 |
| Blair William & Co | 912.5K | $1.0M | 1.33% | -9.9K | 2026-06-30 |
| Geode Capital Management, LLC | 820.1K | $1.0M | 1.20% | -779.6K | 2026-06-30 |
| Jane Street Group, LLC | 688.9K | -- | 1.01% | +648.8K | 2026-06-30 |
| UBS Group AG | 638.7K | -- | 0.93% | +238.1K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 410.6K | -- | 0.60% | -35.6K | 2026-06-30 |